272 related articles for article (PubMed ID: 29180475)
1. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes.
Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER
Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475
[TBL] [Abstract][Full Text] [Related]
2. The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior.
Bornachea O; López-Calderón FF; Dueñas M; Segrelles C; Lorz C; Suárez-Cabrera C; Marañón M; Paradela-Dobarro B; Santos M; Paramio JM
Oncotarget; 2015 Sep; 6(27):24230-45. PubMed ID: 26203771
[TBL] [Abstract][Full Text] [Related]
3. p63 isoforms in triple-negative breast cancer: ΔNp63 associates with the basal phenotype whereas TAp63 associates with androgen receptor, lack of BRCA mutation, PTEN and improved survival.
Coates PJ; Nenutil R; Holcakova J; Nekulova M; Podhorec J; Svoboda M; Vojtesek B
Virchows Arch; 2018 Mar; 472(3):351-359. PubMed ID: 29484502
[TBL] [Abstract][Full Text] [Related]
4. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
5. TAp63 and DeltaNp63 in cancer and epidermal development.
Candi E; Dinsdale D; Rufini A; Salomoni P; Knight RA; Mueller M; Krammer PH; Melino G
Cell Cycle; 2007 Feb; 6(3):274-85. PubMed ID: 17264681
[TBL] [Abstract][Full Text] [Related]
6. TP63 isoform expression is linked with distinct clinical outcomes in cancer.
Bankhead A; McMaster T; Wang Y; Boonstra PS; Palmbos PL
EBioMedicine; 2020 Jan; 51():102561. PubMed ID: 31927310
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
8. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
[TBL] [Abstract][Full Text] [Related]
9. ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma.
Katoh I; Tsukinoki K; Hata RI; Kurata SI
Neoplasia; 2023 Nov; 45():100938. PubMed ID: 37778252
[TBL] [Abstract][Full Text] [Related]
10. A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues.
Sethi I; Romano RA; Gluck C; Smalley K; Vojtesek B; Buck MJ; Sinha S
BMC Genomics; 2015 Aug; 16():584. PubMed ID: 26251276
[TBL] [Abstract][Full Text] [Related]
11. Dynamic life of a skin keratinocyte: an intimate tryst with the master regulator p63.
Romano RA; Sinha S
Indian J Exp Biol; 2011 Oct; 49(10):721-31. PubMed ID: 22013738
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress Responses.
Napoli M; Deshpande AA; Chakravarti D; Rajapakshe K; Gunaratne PH; Coarfa C; Flores ER
Cancer Res Commun; 2024 Feb; 4(2):264-278. PubMed ID: 38165157
[TBL] [Abstract][Full Text] [Related]
13. Expression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.
Mitani Y; Li J; Weber RS; Lippman SL; Flores ER; Caulin C; El-Naggar AK
Am J Pathol; 2011 Jul; 179(1):391-9. PubMed ID: 21703418
[TBL] [Abstract][Full Text] [Related]
14. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
[TBL] [Abstract][Full Text] [Related]
15. [The two faces of p63, Janus of the p53 gene family].
Caron de Fromentel C; Aberdam E; Aberdam D
Med Sci (Paris); 2012 Apr; 28(4):381-7. PubMed ID: 22549865
[TBL] [Abstract][Full Text] [Related]
16. Distinct expression profiles of p63 variants during urothelial development and bladder cancer progression.
Karni-Schmidt O; Castillo-Martin M; Shen TH; Gladoun N; Domingo-Domenech J; Sanchez-Carbayo M; Li Y; Lowe S; Prives C; Cordon-Cardo C
Am J Pathol; 2011 Mar; 178(3):1350-60. PubMed ID: 21356385
[TBL] [Abstract][Full Text] [Related]
17. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
[TBL] [Abstract][Full Text] [Related]
18. A double dealing tale of p63: an oncogene or a tumor suppressor.
Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C
Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366
[TBL] [Abstract][Full Text] [Related]
19. ΔNp63 knockout mice reveal its indispensable role as a master regulator of epithelial development and differentiation.
Romano RA; Smalley K; Magraw C; Serna VA; Kurita T; Raghavan S; Sinha S
Development; 2012 Feb; 139(4):772-82. PubMed ID: 22274697
[TBL] [Abstract][Full Text] [Related]
20. Spatiotemporal Regulation of ΔNp63 by TGFβ-Regulated miRNAs Is Essential for Cancer Metastasis.
Bui NHB; Napoli M; Davis AJ; Abbas HA; Rajapakshe K; Coarfa C; Flores ER
Cancer Res; 2020 Jul; 80(13):2833-2847. PubMed ID: 32312834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
